DoseMeRx
By DoseMeRx
DoseMeRx is the world's leading Bayesian dosing platform. It is the largest of its kind and uses cutting-edge technology combined with evidence-based science to provide clinicians with an accurate individualized dose in mere seconds. It uses clinically-validated pharmacokinetic drug models, patient characteristics, drug concentrations and genotype to make this possible. Healthcare professionals who use this platform are able to save time on calculations and devote more time to providing the best possible care for their patients.
Pricing of DoseMeRx
- Simulate predicted outcomes
- Flexible timing
- Seamless Integration
- Easily interpret model
- Fast Implementation
- Reliable
- Simulate predicted outcomes
- Flexible timing
- Seamless Integration
- Easily interpret model
- Fast Implementation
- Reliable
Key Specification
| Other Categories: | New Saas Software |
|---|---|
| Deployment: | Cloud Hosted |
| Customer Support: | Phone,Online (Ticket) |
| Customization: | No |
| Languages Support: | English |
Who uses DoseMeRx
SMEs
Enterprises
Company Details
| Company Name: | DoseMeRx |
|---|---|
| Headquarter: | Moorestown, |
| Social Media: |
Most Popular Software
Friday.app
Free Your Friday
Spotlight
your voice can
Fin Analytics
Amplify what's possible with your CX operations teams
pdfDocs
pdfDocs takes the work out of creating complex PDFs. GET A DEMO
Spayee
CREATE, PROMOTE AND SELL COURSES EFFORTLESSLY WITH SPAYEE
Centered
Stressed out and overworked.
Alternative
Friday.app
Free Your Friday
Spotlight
your voice can
Fin Analytics
Amplify what's possible with your CX operations teams
DoseMeRx Video
User Reviews
Frequently Asked Questions (FAQs)
The user group of DoseMeRx are as follows :
- Enterprises
- SMEs
- SMEs
DoseMeRx has 1 plans,
- DoseMeRx USD 0.00
DoseMeRx is allowed 0 Days Free Trial.
DoseMeRx pricing model : Onetime(Perpetual License)
DoseMeRx is Online Software.
No
DoseMeRx offers Phone,Online (Ticket) support.
DoseMeRx provides Help Guides,Blogs,Video Guides for the software training.
